What is the impact of EMA decisions on cancer patients in Europe?
EMA decisions directly impact the availability and quality of cancer treatments for patients across Europe. By approving new and effective treatments, the EMA helps improve survival rates, quality of life, and overall patient outcomes. Furthermore, the EMA's stringent evaluation process ensures that patients have access to safe and high-quality medications.
